SWOT Analysis for Relay Therapeutics Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)

Negative Breakdown Second Support (LTP < S2)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter